Wealth Enhancement Trust Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Wealth Enhancement Trust Services’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$706	Buy	+35	New	+$706	﹤0.01%	1190

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Denali Advisors San Diego, California $993M AUM 34.77% 1-Year Est. Return

BCC

Bridge City Capital Lake Oswego, Oregon $438M AUM 64.84% 1-Year Est. Return

Wealth Enhancement Trust Services's AMPH Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 35 shares worth $706. The stake represents ﹤0.01% of the portfolio and ranks #1190 among its holdings.

129 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Wealth Enhancement Trust Services held 35 shares of Amphastar Pharmaceuticals worth $706 as of Q2 2026.
Amphastar Pharmaceuticals was a new Wealth Enhancement Trust Services position in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1190 holding.
129 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.